Advertisements

Stocking Stuffers

 

Inogen Inc (INGN) Stock Quote

Detailed Quote for Inogen Inc (INGN)
$ 150.13   1.59 (+1.07%) Volume: 558.39k 4:00 PM EST Jan 18, 2019
After Hours:  $ 150.13 0.00 (0.00%) Volume: 16.13k 6:19 PM EST Jan 18, 2019
Today 5d 1m 3m 1y more
Last Price
150.13
Change $
1.59
Change %
1.07%
Tick
  
Bid
148.60
Bid Size
100
Ask
150.80
Ask Size
100
Open
150.22
High
152.74
Low
149.485
Prev Close
148.54
Last Trade
01/18/19
Volume
558.39k
52 Wk Hi
287.790008
52 Wk Low
110.510101
Market Cap
3.23b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
21,522,602
EPS (TTM)
1.83000004
PE Ratio
82.00
Exchange
NGS
News and Media for Inogen Inc (INGN)
Sector News | Topic News
News for Inogen Inc (INGN)
Thu, Jan 17, 2019
10:54 AM Inogen (INGN) To Present At 21st Annual Needham Growth Conference - Slideshow - SeekingAlpha
Fri, Jan 11, 2019
8:00 AM Today's Research Reports on Trending Tickers: Tandem Diabetes Care and Inogen - ACCESSWIRE IA
Thu, Jan 10, 2019
10:32 AM Inogen (INGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow - SeekingAlpha
Mon, Jan 07, 2019
7:14 AM Inogen: More Appealing, Not Appealing Enough - SeekingAlpha
Wed, Jan 02, 2019
4:05 PM Inogen Announces Participation in the 21st Annual Needham Growth Conference - Business Wire
4:05 PM Inogen Announces Participation in the 2019 J.P. Morgan Healthcare Conference - Business Wire
Tue, Dec 18, 2018
9:00 AM Inogen Announces Launch of Inogen Connect - Business Wire
Fri, Nov 23, 2018
8:10 AM Report: Exploring Fundamental Drivers Behind Graphic Packaging Holding, QEP Resources, Inogen, CytRx, Voyager Therapeutics, and Daily Journal Corp. (S.C.) - New Horizons, Emerging Trends, and Upcoming Developments - GlobeNewswire
Tue, Nov 20, 2018
4:05 PM Inogen Announces Participation in Nasdaq's 39th London Investor Conference - Business Wire
More News for INGN >>
Filings for Inogen Inc (INGN)
Wed, Jan 16, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Mon, Jan 07, 2019
3:00 AM Report of unscheduled material events or corporate changes - Form 8-K
Wed, Jan 02, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Tue, Dec 18, 2018
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Thu, Dec 06, 2018
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Mon, Dec 03, 2018
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Thu, Nov 29, 2018
3:00 AM Statement of beneficial ownership of common stock by certain persons - Form SC 13G
More Filings for INGN >>

Tags for Inogen Inc

Research stocks or mutual funds related to Inogen Inc by keywords or tags. Find companies that have a similar focus to INGN. The keywords below have been associated to INGN by either user submission or electronic means.

advanced therapy manufacturing contracts pharmaceutical industry strategy pharmaceutical market pivotal therapy system generic pharmaceutical contract manufacturing organisation introgen pharmaceutical research and development pharmaceutical manufacturing company chemotherapy pharmaceutical software oncology treatment pharma manufacturing pharmaceutical clinical research pharma license pfizer pharmaceutical company novartis pharmaceuticals kv pharmaceutical company gmp pharmaceutical pharmaceutical cro clinical trials industry pharmaceutical development pharmaceutical magazine Drugs pharma clinical trials pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article contract pharmaceutical pharmaceutical consulting pharmaceutical events pharmaceutical industry biotech contract cell therapies clinical trials europe pharmaceutical strategy pharmaceutical advances live cell therapy pharmaceutical out licensing Healthcare pharmaceutical contract research organizations pharmaceutical sector bio pharmaceuticals pharmaceutical innovation pharmaceutical pharmaceutical industry research contract pharma